Tanja Jovanović (Tanja Jovanovic)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Aortic Dissection

Patients Undergoing

Epstein Barr Virus

Acute Lymphoblastic Leukemia

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Marko Janković, Tara Knezevic, Ana Tomic, Ognjen Milicevic, Tanja Jovanović, Irena Djunic, Biljana Mihaljevic, Aleksandra Knežević, Milena Todorović Balint
Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy. International journal of molecular sciences 25 (7) (2024)
Tamara Vasiljevic, Marko Janković, Ana Tomic, Ida Bakrac, Stefan Radenovic, Danijela Karalic, Aleksandra Knežević, Tanja Jovanović, Irena Djunic, Milena Todorović Balint
Significance of Cytomegalovirus gB Genotypes in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation: Insights from a Single-Centre Investigation. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Marija Vukčević, Katarina Šerović, Mateja Despot, Aleksandra Nikolić Kokić, Aleksandra Vujović, Milan Nikolić, Duško Blagojević, Tanja Jovanović, Dragana Despot
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Marija Vukčević, Katarina Šerović, Mateja Despot, Aleksandra Nikolić Kokić, Aleksandra Vujović, Milan Nikolić, Duško Blagojević, Tanja Jovanović, Dragana Despot
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Marija Vukčević, Katarina Šerović, Mateja Despot, Aleksandra Nikolić Kokić, Aleksandra Vujović, Milan Nikolić, Duško Blagojević, Tanja Jovanović, Dragana Despot
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Marko Janković, Tara Knezevic, Ana Tomic, Ognjen Milicevic, Tanja Jovanović, Irena Djunic, Biljana Mihaljevic, Aleksandra Knežević, Milena Todorović Balint
Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy. International journal of molecular sciences 25 (7) (2024)
Marko Janković, Tara Knezevic, Ana Tomic, Ognjen Milicevic, Tanja Jovanović, Irena Djunic, Biljana Mihaljevic, Aleksandra Knežević, Milena Todorović Balint
Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy. International journal of molecular sciences 25 (7) (2024)
Tamara Vasiljevic, Marko Janković, Ana Tomic, Ida Bakrac, Stefan Radenovic, Danijela Karalic, Aleksandra Knežević, Tanja Jovanović, Irena Djunic, Milena Todorović Balint
Significance of Cytomegalovirus gB Genotypes in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation: Insights from a Single-Centre Investigation. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)